BSPM [Biostar Pharmaceuticals,] 8-K: Biostar Pharmaceuticals, Reports First Quarter 2011 Results; Revenuesrease
[Biostar Pharmaceuticals, Reports First Quarter 2011 Results; Revenuesrease 24% to $15.3 Million withjusted EPS of $0.11 XIANYANG, China, May 16, 2011 -- Biostar Pharmaceuticals, (Nasdaq: BSPM) ("Biostar" or "thempany"), Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acidpsules ("Xin Aoxingpsules"), and a variety of pharmaceutical products, today announced financial results for]